Actively Recruiting
A Crowd Sourcing Platform for Patients With Cancer
Led by All4Cure · Updated on 2024-07-30
5000
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
This research aims to improve understanding and treatment of cancer by creating an online platform where patients, doctors, and researchers can share medical information and research findings. The study tests the idea that this shared knowledge will help patients better understand their condition, support doctors in making treatment decisions, and speed up cancer research progress. The study involves cancer patients who have been diagnosed and are receiving medical care. Participants do not receive any active treatment as part of this observational study. Instead, leftover blood, bodily fluids, or tissue samples collected during routine clinical care will be analyzed. The results of these analyses will be shared on the All4Cure website to build a shared knowledge base accessible to patients, clinicians, and scientists. There are no experimental interventions or treatments administered. During the study, patients will contribute by allowing their leftover clinical samples to be used for research. Researchers will monitor changes in tumor molecular profiles over six years to learn more about cancer. Participants' health information will be shared anonymously on the platform to help accelerate research. The study does not involve additional treatments, and participation involves data sharing and sample analysis only.
CONDITIONS
Brief Title
A Crowd Sourcing Platform for Patients With Cancer
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Have been diagnosed with cancer.
- Be under the care of a physician.
- Be 18 years of age or older.
You will not qualify if you...
History of severe allergic reactions to study medication Currently pregnant or breastfeeding Recent participation in another clinical trial within the last 30 days Presence of uncontrolled medical conditions that could affect safety
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - Up to 6 years
Leftover blood, bodily fluids, and/or tissue samples collected for clinical purposes are obtained for analysis.
Duration - Up to 6 years
Participants' tumor tissue molecular profiles are observed over time through data shared on the online platform.
Trial Site Locations
Total: 1 location
1
All4Cure
Seattle, Washington, United States, 98136
Actively Recruiting
Research Team
C
Carl A Blau, MD
K
Kimberly A Burton, PhD
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here